Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ABBVIE

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 22
  • 0 comments

FDA approve DIVALPROEX SODIUM

Comment Full text

ABBVIE

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 24
  • 0 comments

FDA approve DIVALPROEX SODIUM

Comment Full text

UPSHER SMITH LABS

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 31
  • 0 comments

FDA approve FAMOTIDINE

Comment Full text

ZYDUS

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 33
  • 0 comments

FDA approve FINASTERIDE; TADALAFIL

Comment Full text

CHARTWELL

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 29
  • 0 comments

FDA approve ACETAMINOPHEN; HYDROCODONE BITARTRATE

Comment Full text

JANSSEN PRODS

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 25
  • 0 comments

FDA approve RILPIVIRINE

Comment Full text

ZYDUS

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 29
  • 0 comments

FDA approve CHLORPROMAZINE HYDROCHLORIDE

Comment Full text

CHARTWELL RX

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 33
  • 0 comments

FDA approve ARIPIPRAZOLE

Comment Full text

DR REDDYS

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 30
  • 0 comments

FDA approve SAPROPTERIN DIHYDROCHLORIDE

Comment Full text

DR REDDYS

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 31
  • 0 comments

FDA approve SAPROPTERIN DIHYDROCHLORIDE

Comment Full text
  • Previous
  • 502
  • 503
  • 504
  • 505
  • 506
  • Next

Search

News categories

  • Technical Exchange News(11751)
  • Event(4196)
  • SEC News(234456)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(143033)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin